Team:Washington/Project/Safety/Secretion

From 2010.igem.org

(Difference between revisions)
m
 
(3 intermediate revisions not shown)
Line 25: Line 25:
</html>
</html>
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
-
Our work on Gram-negative Therapeutics was done only on non-pathogenic strains.  We used the Type VI Secretion System from ''Pseudomonas aeruginosa'' PAO1.  All modifications and testing of plasmids and fosmids were in non-pathogenic E. Coli strains, namely EPI300, SW102, and BL21.  And Team Tse2's strain...MPI??
+
Our work on Gram-negative Therapeutics was done only on non-pathogenic strains.  We used the Type VI Secretion System from ''Pseudomonas aeruginosa'' PAO1.  All modifications and testing of plasmids and fosmids were in non-pathogenic ''E. Coli'' strains, namely EPI300, SW102, and BL21.  All cloning and testing of Tse2 was done in the non-pathogenic ''E. coli'' strains DH5a, MG1655, and BL21.
-
 
+
The toxin we work with, Tse2, targets only prokaryotic cells, thus posing no direct danger to humans. At no time was a working type six secretion system placed into ''E. coli'' producing Tse2. Therefore, none of the strains could cause any possible ecological danger.
-
The toxin we work with, Tse2, is targeted only to prokaryotic cells so does not pose any danger.
+
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->

Latest revision as of 00:17, 14 September 2010

Our work on Gram-negative Therapeutics was done only on non-pathogenic strains. We used the Type VI Secretion System from Pseudomonas aeruginosa PAO1. All modifications and testing of plasmids and fosmids were in non-pathogenic E. Coli strains, namely EPI300, SW102, and BL21. All cloning and testing of Tse2 was done in the non-pathogenic E. coli strains DH5a, MG1655, and BL21. The toxin we work with, Tse2, targets only prokaryotic cells, thus posing no direct danger to humans. At no time was a working type six secretion system placed into E. coli producing Tse2. Therefore, none of the strains could cause any possible ecological danger.

Anthrax Work       Meet the Team